• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma USA 2023: Digital Therapeutics and Pharma

Article

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Related Videos
Related Content
Chris Martin, Chief Commercial Officer, Verona Pharma.

Lessons Learned on the Art and Science of Product Commercialization

April 19th 2024
Article

Insight that can help smaller biotech companies prepare for commercialization in the world of big pharma.

Sandra Von Meier

Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology

April 18th 2024
Article

Unique approaches are needed to bring solutions to fighting cancer and bacterial-resistant infections.

Say Hello to Flexible: Reimagining the Patient Journey

Say Hello to Flexible: Reimagining the Patient Journey

April 15th 2024
Article

Through embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.

Positioning Medical Information as a Trust Driver for Your Brand

Positioning Medical Information as a Trust Driver for Your Brand

March 12th 2024
Article

Four steps to maximize the impact of medical information services as an engagement gateway.

Peter Stark

Redefining Commercial with Modern Data for Today’s Complex Therapies: Q&A with Peter Stark, Executive VP and General Manager of Veeva Compass

March 4th 2024
Article

Stark discusses how the ways that data is reshaping commercial strategies.

Beyond Medicines: Pharma's Journey with Patient Family Advisory Councils

Beyond Medicines: Pharma's Journey with Patient Family Advisory Councils

February 1st 2024
Article

Including patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.